| [1] |
.
[J]. Clinical Focus, 2023, 38(12): 1140-1145.
|
| [2] |
Yang Jinqiang, Zhang Renmin.
Prognostic value of procalcitonin to platelet ratio in patients with fever with thrombocytopenia syndrome
[J]. Clinical Focus, 2023, 38(4): 346-351.
|
| [3] |
Wu Qiong, Sun Feng, Zhang Kai, Wang Zhiyi, Zhang Nana, Cheng Hui, Xiang Yang, Chang Xiaohui.
Curative effect of combination of eltrombopag and low-dose prednisone on refractory and relapsed primary immune thrombocytopenia in elderly patients
[J]. Clinical Focus, 2022, 37(11): 1008-1011.
|
| [4] |
.
[J]. Clinical Focus, 2021, 36(12): 1139-1143.
|
| [5] |
Fu Haixia.
Study on standardized diagnosis and treatment of primary immune thrombocytopenia
[J]. Clinical Focus, 2021, 36(10): 896-900.
|
| [6] |
Wang Jing;Li Ruibin;Cui Wei.
Analysis of characteristics and risk factors of acute serious thrombocytopenia associated with tirofiban in Chinese patients
[J]. Clinical Focus, 2015, 30(4): 361-366.
|
| [7] |
PENG Jun.
Advances in the treatment of refractory/relapsed immune thrombocytopenia
[J]. Clinical Focus, 2014, 29(10): 1091-1094.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2013, 28(11): 1292-1293.
|
| [9] |
.
[J]. Clinical Focus, 2012, 27(22): 0-0.
|
| [10] |
.
[J]. Clinical Focus, 2012, 27(20): 1833-1836.
|
| [11] |
.
[J]. Clinical Focus, 2012, 27(6): 547-0.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2011, 26(11): 984-985.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2011, 26(7): 604-605.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(20): 1815-1816.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2010, 25(4): 359-361.
|
